A detailed history of Colonial Trust Advisors transactions in Zoetis Inc. stock. As of the latest transaction made, Colonial Trust Advisors holds 32,191 shares of ZTS stock, worth $5.65 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
32,191
Previous 30,196 6.61%
Holding current value
$5.65 Million
Previous $5.23 Million 20.16%
% of portfolio
0.55%
Previous 0.51%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $344,297 - $391,977
1,995 Added 6.61%
32,191 $6.29 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $460,197 - $565,460
3,162 Added 11.7%
30,196 $5.23 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $250,493 - $302,309
1,512 Added 5.92%
27,034 $4.57 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $478,247 - $631,884
3,158 Added 14.12%
25,522 $5.04 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $484,538 - $558,840
2,899 Added 14.89%
22,364 $3.89 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $186,851 - $216,213
1,161 Added 6.34%
19,465 $3.35 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $96,889 - $116,563
666 Added 3.78%
18,304 $3.05 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $167,859 - $201,561
-1,280 Reduced 6.77%
17,638 $2.59 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $2.81 Million - $3.45 Million
18,918 New
18,918 $2.81 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $75,645 - $97,043
-485 Reduced 2.69%
17,551 $3.02 Million
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $60,040 - $77,463
331 Added 1.87%
18,036 $3.4 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $98,394 - $125,491
508 Added 2.95%
17,705 $4.32 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $73,444 - $81,359
388 Added 2.31%
17,197 $3.34 Million
Q2 2021

Aug 05, 2021

BUY
$155.9 - $187.99 $2.62 Million - $3.16 Million
16,809 New
16,809 $3.13 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.